1.
Ludwigshafen, July 27, 2017
Analyst Conference Call Q2 2017

2.
BASF Q2 2017 Analyst Conference Call, July 27, 2017 2
Cautionary note regarding
forward-looking statements
This presentation contains forward-looking statements. These forward-looking statements are based
on current estimates and projections of the Board of Executive Directors and on currently available
information. These forward-looking statements are not guarantees of the future developments and
results outlined therein. Rather, they depend on a number of factors, involve various risks and
uncertainties, and are based on assumptions that may not prove to be accurate. Such risk factors
particularly include those discussed on pages 111 to 118 of the BASF Report 2016. The BASF
Report is available online at basf.com/report. BASF does not assume any obligation to update the
forward-looking statements contained in this presentation.

3.
BASF Q2 2017 Analyst Conference Call, July 27, 2017 3
BASF Group Q2 2017
Considerably higher sales and earnings
Financial figures Q2 2017 Q2 2016 Change
Sales €16.3 billion €14.5 billion 12%
EBITDA before special items €3.3 billion €2.7 billion 23%
EBITDA €3.2 billion €2.8 billion 16%
EBIT before special items €2.3 billion €1.7 billion 32%
EBIT €2.2 billion €1.7 billion 27%
Net income €1.5 billion €1.1 billion 37%
Reported EPS €1.63 €1.19 37%
Adjusted EPS €1.78 €1.30 37%
Operating cash flow €3.0 billion €2.3 billion 29%
Sales development Volumes Prices Portfolio Currencies
Q2 2017 vs. Q2 2016 3% 7% 1% 1%   

4.
BASF Q2 2017 Analyst Conference Call, July 27, 2017 4
Milestones
BASF plans new
automotive application
center for Asia Pacific
BASF to invest in ibuprofen
capacities in Germany and
North America
BASF and Norilsk Nickel
to cooperate on raw
material supply for battery
materials production
BASF and Kaiima
to identify novel herbicide
resistance traits

5.
BASF Q2 2017 Analyst Conference Call, July 27, 2017 5
Chemicals
Higher earnings driven by increased margins
Intermediates
757
+11%
Monomers
1,708
+38%
Petrochemicals
1,580
+20%
€4,045
+25%
Sales Q2 2017 vs. Q2 2016*
million €
EBIT before special items*
million €
458 488
629
958
1,120
0
200
400
600
800
1,000
1,200
Q2 Q3 Q4 Q1 Q2
Sales development Volumes Prices Portfolio Currencies
Q2 2017 vs. Q2 2016 (1%) 25% 0% 1%
2016 2017
* Effective January 1, 2017, the Monomers and Dispersions & Pigments divisions’ activities for the electronics industry were merged into the global Electronic Materials business unit
and allocated to the Dispersions & Pigments division in the Performance Products segment. The 2016 figures have been adjusted accordingly.
  

6.
BASF Q2 2017 Analyst Conference Call, July 27, 2017 6
Performance Products
Sales increased, earnings declined due to lower margins
Performance Chemicals
980
+2%
Nutrition & Health
464
(7%)
Care Chemicals
1,263
+7%
€4,142
+4%
Sales development Volumes Prices Portfolio Currencies
Q2 2017 vs. Q2 2016 2% 2% (1%) 1%

512
473
237
515
405
0
200
400
600
800
Q2 Q3 Q4 Q1 Q2
EBIT before special items*
million €
Sales Q2 2017 vs. Q2 2016*
million €
2016 2017
Dispersions & Pigments
1,435
+6%
* Effective January 1, 2017, the Monomers and Dispersions & Pigments divisions’ activities for the electronics industry were merged into the global Electronic Materials business unit
and allocated to the Dispersions & Pigments division in the Performance Products segment. The 2016 figures have been adjusted accordingly.
  

7.
BASF Q2 2017 Analyst Conference Call, July 27, 2017 7
Functional Materials & Solutions
Sales growth on good demand, earnings affected by lower margins overall
and higher fixed costs
Coatings
998
+25%
Catalysts
1,674
+11%
Construction
Chemicals
646
+3%
Performance Materials
1,943
+10%
€5,261
+12%
535
497
458
531
422
0
200
400
600
800
Q2 Q3 Q4 Q1 Q2
EBIT before special items
million €
Sales development Volumes Prices Portfolio Currencies
Q2 2017 vs. Q2 2016 4% 3% 3% 2%
2016 2017
Sales Q2 2017 vs. Q2 2016
million €
   

8.
BASF Q2 2017 Analyst Conference Call, July 27, 2017 8
1,459 1,526
3,239 3,381
0
1,000
2,000
3,000
4,000
Q2 2016 Q2 2017 H1 2016 H1 2017
Agricultural Solutions
Sales increased, earnings impacted by lower average margins due to different product mix
320
272
911
805
0
200
400
600
800
1,000
Q2 2016 Q2 2017 H1 2016 H1 2017
EBIT before special items Q2 2017 vs. Q2 2016 and
H1 2017 vs. H1 2016, million €
Sales development Volumes Prices Portfolio Currencies
Q2 2017 vs. Q2 2016 5% (2%) 0% 2%
Sales Q2 2017 vs. Q2 2016 and
H1 2017 vs. H1 2016, million €
+5%
+4%
(15%)
(12%)




9.
BASF Q2 2017 Analyst Conference Call, July 27, 2017 9
Oil & Gas
Sales and earnings up, mainly due to higher volumes and prices
Sales Q2 2017 vs. Q2 2016
million €
94
183
100
122
0
100
200
300
Q2 2016 Q2 2017
EBIT before special items, net income
million €
Sales development Volumes Prices/Currencies Portfolio
Q2 2017 vs. Q2 2016 22% 10% 0%
EBIT before special items Net income
+32%
617
814
0
500
1,000
Q2 2016 Q2 2017


10.
BASF Q2 2017 Analyst Conference Call, July 27, 2017 10
Review of “Other”
million € Q2 2017 Q2 2016
Sales 476 485
EBIT before special items (151) (212)
Thereof Costs for cross-divisional corporate research (93) (88)
Costs of corporate headquarters (58) (56)
Foreign currency results, hedging and other measurement effects 142 (116)
Other businesses (12) 33
Special items (30) 65
EBIT (181) (147)

11.
BASF Q2 2017 Analyst Conference Call, July 27, 2017 11
Cash flow development in 1st half 2017
million € H1 2017 H1 2016
Cash provided by operating activities 3,802 3,339
Thereof Changes in net working capital (1,684) (1,045)
Miscellaneous items 178 (122)
Cash used in investing activities (2,365) (1,988)
Thereof Payments made for tangible / intangible assets (1,642) (1,979)
Acquisitions / divestitures (65) 51
Cash used in financing activities (886) (1,814)
Thereof Changes in financial liabilities 1,932 944
Dividends (2,837) (2,768)
Free cash flow 2,160 1,360

12.
BASF Q2 2017 Analyst Conference Call, July 27, 2017 12
Outlook 2017 for BASF Group raised
Outlook 2017
We have raised our 2017 forecast as follows (previous forecast in parentheses):
▪ Considerable sales increase (considerable increase)
▪ Considerable increase in EBIT before special items and in EBIT (slight increase)
▪ Significant premium on cost of capital with slight increase in EBIT after cost of capital
(considerable decline in EBIT after cost of capital)
GDP growth: +2.5% (+2.3%)
Growth in industrial production: +2.5% (+2.3%)
Growth in chemical production*: +3.4% (+3.4%)
Exchange rate: US$1.10 per euro (US$1.05 per euro)
Oil price (Brent): US$50 per barrel (US$55 per barrel)
* Excluding pharma
Assumptions 2017

13.
BASF Q2 2017 Analyst Conference Call, July 27, 2017 13
BASF Investor Day 2015 – Keynote speech 13